NCT03252743

Brief Summary

This open trial aims to evaluate feasibility and preliminary effectiveness of an internet-delivered CBT-program for children and adolescents with functional gastrointestinal disorders when implemented in regular care.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
68

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 14, 2017

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 17, 2017

Completed
15 days until next milestone

Study Start

First participant enrolled

September 1, 2017

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 17, 2018

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 18, 2018

Completed
Last Updated

February 26, 2019

Status Verified

February 1, 2019

Enrollment Period

10 months

First QC Date

August 14, 2017

Last Update Submit

February 25, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Global gastrointestinal symptoms (CSI-24: subscale 7 items on GI-symptoms).

    Change in global gastrointestinal symptoms from baseline to 10 weeks.

    Baseline to 10 weeks.

Secondary Outcomes (17)

  • Pain intensity (Faces Pain rating scale)

    Baseline to 10 weeks

  • Pain intensity (Faces Pain rating scale)

    Baseline to 5 months.

  • Pain intensity (Faces Pain rating scale)

    Baseline to 8 months.

  • Global gastrointestinal symptoms (CSI-24: subscale 7 items on GI-symptoms).

    Baseline to 5 months.

  • Global gastrointestinal symptoms (CSI-24: subscale 7 items on GI-symptoms).

    Baseline to 8 months.

  • +12 more secondary outcomes

Other Outcomes (3)

  • Parental responses to children´s symptom behavior (ARCS)

    Baseline to 10 weeks.

  • Parental responses to children´s symptom behavior (ARCS)

    Baseline to 5 months.

  • Parental responses to children´s symptom behavior (ARCS)

    Baseline to 8 months.

Study Arms (1)

Internet-delivered CBT

EXPERIMENTAL

Exposure-based internet-delivered CBT with ten weekly modules distributed over the internet during ten weeks, and weekly therapist support over the internet.

Behavioral: Exposure-based internet-delivered CBT

Interventions

The main target in treatment is exposure for abdominal symptoms by reducing avoidance and provoking symptoms. Participants are encouraged to gradually increase the difficulty by combining multiple challenges. The parents are taught how to reduce the risk for reinforcement of children's symptom behavior, and to support their child to complete the treatment. All treatment content is delivered over the internet, containing texts, videos, audio-files and examples. The modules are unlocked sequentially as participants worked their way through the treatment. Therapist support consists primarily of encouragement of any progress made in the treatment and support to find individual exercises.

Internet-delivered CBT

Eligibility Criteria

Age8 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Fulfilling Rome IV-criteria for irritable bowel syndrome, functional dyspepsia or functional abdominal pain with a written statement from patient's physician confirming a diagnosis.
  • Stable psychotropic medication for at least 1 month.

You may not qualify if:

  • concurrent serious medical conditions.
  • a psychiatric diagnosis, judged to be a more important treatment target than the abdominal pain.
  • on-going structured psychological treatment.
  • on-going abuse or severe parental psychiatric illness in the family.
  • lack of regular internet-access.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Clinical Neuroscience, Karolinska Institutet

Stockholm, Sweden

Location

Related Links

MeSH Terms

Conditions

Gastrointestinal DiseasesIrritable Bowel SyndromeDyspepsia

Condition Hierarchy (Ancestors)

Digestive System DiseasesColonic Diseases, FunctionalColonic DiseasesIntestinal DiseasesSigns and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Marianne Bonnert, PhD

    Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Open trial without control group to test feasibility and evaluate preliminary effects.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD

Study Record Dates

First Submitted

August 14, 2017

First Posted

August 17, 2017

Study Start

September 1, 2017

Primary Completion

June 17, 2018

Study Completion

December 18, 2018

Last Updated

February 26, 2019

Record last verified: 2019-02

Locations